Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Animal models are crucial for learning about hair loss and finding treatments.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Prolactin affects when mice shed and grow hair.

Men with hair loss have higher BMI, waist size, blood pressure, and are linked to smoking and inactivity.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Dutasteride caused more penile tissue changes than finasteride, possibly increasing erectile dysfunction risk.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Various treatments exist for hair loss, but more research is needed for better options.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Minoxidil and spironolactone combo effectively treats androgenetic alopecia, improving hair density and diameter.

Men and premenopausal women in Korea show different patterns in iron and vitamin D levels, with no clear pattern for postmenopausal women.

No clear link between finasteride use and acute pancreatitis risk.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.